Abbott to market SmithKline Helicobacter pylori test:
This article was originally published in Clinica
Beckman Instruments' SmithKline Diagnostics subsidiary has given worldwide marketing rights to Abbott for its rapid, office-based H pylori test. To be marketed under the name FlexPack HP, the serum test involves a three-step procedure, providing results within five minutes. The test complements Abbott's peptic ulcer business, which includes the antibiotic, clarithromycin, which is pending US approval for use in treating H pylori infection.
You may also be interested in...
Turku, Finland-based Forendo Pharma has entered into a license and collaboration deal with Novartis involving the identification of novel drugs to treat chronic liver diseases.
Three accelerated assessment requests will either be granted or rejected this week at the European Medicines Agency.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.